Syracuse, New York 13210


Purpose:

Some patients who undergo breast cancer treatment with lumpectomy followed by radiation therapy develop significant late skin and soft tissue changes, resulting in a poor cosmetic outcome. The goal of this study is to try to predict severe tissue reactions by using a combination of three of the latest blood tests, one of which we have developed ourselves.


Study summary:

Three tubes of blood will be drawn from each subject. Two members of the study team will also independently assess each subject for the degree to which various radiation-induced soft tissue changes are evident. Subjects will be put into three groups according to the severity of the soft tissue changes which are noted, and the results of the blood tests for members of each group will be analyzed to determine whether a correlation with cosmetic outcomes can be determined. If the results are promising, they will be studied further and used as the basis for future prospective clinical trials.


Criteria:

Inclusion Criteria: - Breast cancer treatment: lumpectomy followed by external beam XRT to breast - Age at the time of radiotherapy treatment: 45-65 years old - XRT dose to breast: >/= 4500 and </= 5200 cGy, fraction size 180 or 200 cGy - Dose distribution: no area receiving >/= 112% of prescribed dose - Follow-ups: patients must be >/= 2.5 years post-treatment Exclusion Criteria: - Reconstructive surgery to involved breast


NCT ID:

NCT00652678


Primary Contact:

Principal Investigator
Peter J Hahn, PhD
State University of New York - Upstate Medical University

Dena Martin, CRA
Phone: 315-464-5262
Email: martind@upstate.edu


Backup Contact:

N/A


Location Contact:

Syracuse, New York 13210
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.